ReviewMolecular therapy : the journal of the American Society of Gene Therapy2020

Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.

Seren Marsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.